Transcripts Aptose Biosciences Inc. OTC Markets

Stocks

Delayed OTC Markets Other stock markets 18:45:06 18/06/2026 +03			5-day change	1st Jan Change
1.560 ^USD	-3.26%		-3.26%	+5.41%

06-15	Aptose Biosciences Inc. Presents Safety, Response and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML	CI
06-15	Aptose Biosciences Updated Tuscany Trial Data Reported in Oral Presentation at EHA 2026	MT

03-31	Aptose Biosciences Inc. - Shareholder/Analyst Call
22/08/25	Aptose Biosciences Inc. - Shareholder/Analyst Call
27/05/25	Aptose Biosciences Inc. - Shareholder/Analyst Call
27/01/25	Aptose Biosciences Inc. - Shareholder/Analyst Call
05/09/24	Aptose Biosciences Inc. - Shareholder/Analyst Call
18/06/24	Aptose Biosciences Inc. - Shareholder/Analyst Call
15/05/24	Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024
27/03/24	Aptose Biosciences Inc., Q4 2023 Earnings Call, Mar 26, 2024
10/11/23	Aptose Biosciences Inc., Q3 2023 Earnings Call, Nov 09, 2023
30/10/23	Aptose Biosciences Inc. - Special Call
11/08/23	Aptose Biosciences Inc., Q2 2023 Earnings Call, Aug 10, 2023
10/06/23	Aptose Biosciences Inc. - Special Call
23/05/23	Aptose Biosciences Inc. - Shareholder/Analyst Call
09/05/23	Aptose Biosciences Inc., Q1 2023 Earnings Call, May 08, 2023
24/03/23	Aptose Biosciences Inc., Q4 2022 Earnings Call, Mar 23, 2023
11/12/22	Aptose Biosciences Inc. - Special Call
02/11/22	Aptose Biosciences Inc., Q3 2022 Earnings Call, Nov 01, 2022
03/08/22	Aptose Biosciences Inc., Q2 2022 Earnings Call, Aug 02, 2022
02/06/22	Aptose Biosciences Inc. - Special Call
31/05/22	Aptose Biosciences Inc. - Shareholder/Analyst Call
10/05/22	Aptose Biosciences Inc., Q1 2022 Earnings Call, May 09, 2022
23/03/22	Aptose Biosciences Inc., Q4 2021 Earnings Call, Mar 22, 2022
14/12/21	Aptose Biosciences Inc. - Special Call
12/11/21	Aptose Biosciences Inc., Q3 2021 Earnings Call, Nov 11, 2021
04/11/21	Aptose Biosciences Inc. - Special Call